Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 26;8(22):5529-5534.
doi: 10.12998/wjcc.v8.i22.5529.

Osteoprotegerin, interleukin and hepatocyte growth factor for prediction of diabetes and hypertension in the third trimester of pregnancy

Su-Jing Huang  1 , Hong-Wei Wang  1 , Hai-Fang Wu  1 , Qiu-Yuan Wei  1 , Shu Luo  1 , Lin Xu  1 , Hong-Qiong Guan  2
Affiliations

Osteoprotegerin, interleukin and hepatocyte growth factor for prediction of diabetes and hypertension in the third trimester of pregnancy

Su-Jing Huang et al. World J Clin Cases. .

Abstract

Background: Gestational diabetes mellitus (GDM) raises the risk of high blood pressure and may cause a series of life-threatening complications in pregnant women. Screening and management of GDM and gestational hypertension (GH) in pregnancy helps to control and reduce these risks and prevent adverse effects on mothers and their fetuses. Currently, the majority criteria used for screening of diabetes mellitus is oral glucose tolerance tests, and blood pressure test is usually used for the screening and diagnosis of hypertension. However, these criteria might not anticipate or detect all GDM or GH cases. Therefore, new specific predictive and diagnostic tools should be evaluated for this population. This study selected three biomarkers of osteoprotegerin (OPG), interleukin (IL) and hepatocyte growth factor (HGF) for GDM and GH predication and diagnosis.

Aim: To explore the feasibility of changes in placental and serum OPG, IL and HGF as tools for prediction and diagnosis of diabetes and hypertension in pregnant women.

Methods: From January 2018 to January 2019, 44 pregnant women with GDM and GH were selected as an observation group, and 44 healthy pregnant women were selected as a control group in the same period. Serum OPG, IL and HGF were compared between the two groups.

Results: The levels of OPG and HGF in the observation group were lower than in the control group, and the level of IL-1β was higher in the observation group than in the control group (all P < 0.05). Furthermore, OPG and HGF were negatively associated with gestational diabetes and gestational hypertension, while IL-1β was positively associated with GDM complicated with GH (all P < 0.05).

Conclusion: The evaluation of serum OPG, HGF and IL-1β levels in patients with coexistent gestational diabetes complicated with hypertension can predict the degree of disease and play an important role in the follow-up treatment and prognosis prediction.

Keywords: Gestational diabetes mellitus; Gestational hypertension; Hepatocyte growth factor; Interleukin; Osteoprotegerin; Third trimester of pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All authors declare they have no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Romano ME, Gallagher LG, Jackson BP, Baker E, Karagas MR. Maternal urinary cadmium, glucose intolerance and gestational diabetes in the New Hampshire Birth Cohort Study. Environ Res. 2019;179:108733. - PMC - PubMed
    1. Absalom G, Zinga J, Margerison C, van der Pligt P. Associations of dietetic management with maternal and neonatal health outcomes in women diagnosed with gestational diabetes: a retrospective cohort study. J Hum Nutr Diet. 2019;32:728–736. - PubMed
    1. Hetkamp T, Hammer K, Möllers M, Köster HA, Falkenberg MK, Kerschke L, Braun J, Oelmeier de Murcia K, Klockenbusch W, Schmitz R. Fetal adrenal gland size in gestational diabetes mellitus. J Perinat Med. 2019;47:941–946. - PubMed
    1. Lu X, Wu F, Jiang M, Sun X, Tian G. Curcumin ameliorates gestational diabetes in mice partly through activating AMPK. Pharm Biol. 2019;57:250–254. - PMC - PubMed
    1. Zhao H, Tao S. MiRNA-221 protects islet β cell function in gestational diabetes mellitus by targeting PAK1. Biochem Biophys Res Commun. 2019;520:218–224. - PubMed